China National Pharma Holdings Performance Announcement: Net Profit Growth of 76.8% Year-over-Year in 2025

2026-03-19 11:21:22

People’s Financial News, March 17 — China National Pharmaceutical Group (000028) released its 2025 performance forecast on March 17. In 2025, the total operating revenue is 73.416 billion yuan, a decrease of 1.29% year-on-year; net profit attributable to shareholders of the listed company is 1.136 billion yuan, a year-on-year increase of 76.8%. Basic earnings per share are 2.04 yuan. The company’s profit growth this period is mainly due to a decrease of 686 million yuan in asset impairment provisions for goodwill and intangible assets, combined with reductions in rigid costs such as labor and rent resulting from store adjustments.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.